Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-122802
Filing Date
2024-11-07
Accepted
2024-11-07 07:30:24
Documents
65
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vigl-20240930.htm   iXBRL 10-Q 2161803
2 EX-31.1 vigl-ex31_1.htm EX-31.1 18363
3 EX-31.2 vigl-ex31_2.htm EX-31.2 18317
4 EX-32.1 vigl-ex32_1.htm EX-32.1 10874
5 EX-32.2 vigl-ex32_2.htm EX-32.2 10844
  Complete submission text file 0000950170-24-122802.txt   7380914

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vigl-20240930.xsd EX-101.SCH 1024317
68 EXTRACTED XBRL INSTANCE DOCUMENT vigl-20240930_htm.xml XML 1048778
Mailing Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472
Business Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472 857-254-4445
Vigil Neuroscience, Inc. (Filer) CIK: 0001827087 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41200 | Film No.: 241433181
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)